Submit a comment

Immunoreactive β-Endorphin and Adrenocorticotropin in Human Cerebrospinal Fluid
Kazuwa Nakao, … , Naoki Kageyama, Hiroo Imura
Kazuwa Nakao, … , Naoki Kageyama, Hiroo Imura
Published December 1, 1980
Citation Information: J Clin Invest. 1980;66(6):1383-1390. https://doi.org/10.1172/JCI109991.
View: Text | PDF
Research Article

Immunoreactive β-Endorphin and Adrenocorticotropin in Human Cerebrospinal Fluid

Abstract

To elucidate the significance of β-endorphin in human cerebrospinal fluid (CSF), CSF levels of β-endorphin-like immunoreactivity (β-EP-LI) in various diseases were determined by a specific radioimmunoassay and compared with simultaneously determined ACTH-like immunoreactivity (ACTH-LI) levels in CSF. CSF β-EP-LI and ACTH-LI in the control group, consisting of 5 normal subjects and 19 patients with nonendocrine diseases, were 22.2±1.3 and 14.6±0.4 fmol/ml, respectively. CSF levels of these peptides in patients with schizophrenia (n = 19) and acromegaly (n = 10) were not significantly different from those in the control group. Patients with Cushing's disease (n = 7) had significantly lower CSF β-EP-LI and ACTH-LI levels than those in the control group. Four of them showed a parallel increase in CSF β-EP-LI and CSF ACTH-LI levels after the complete removal of pituitary microadenomas (P < 0.05).

Authors

Kazuwa Nakao, Shogo Oki, Issey Tanaka, Kazuko Horii, Yoshikatsu Nakai, Tomoo Furui, Masanori Fukushima, Akio Kuwayama, Naoki Kageyama, Hiroo Imura

×

Guidelines

The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.

  • Comments appear on the Journal’s website and are linked from the original article’s web page.
  • Authors are notified by email if their comments are posted.
  • The Journal reserves the right to edit comments for length and clarity.
  • No appeals will be considered.
  • Comments are not indexed in PubMed.

Specific requirements

  • Maximum length, 400 words
  • Entered as plain text or HTML
  • Author’s name and email address, to be posted with the comment
  • Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
  • Comments may not include figures
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required